Today: 7 February 2026
Subscribe

Bristol-Myers Squibb (BMY) Stock Today: Lawsuit Shock, Breyanzi Momentum and 2026 Forecast

Bristol-Myers Squibb (BMY) Stock Today: Lawsuit Shock, Breyanzi Momentum and 2026 Forecast

Bristol-Myers Squibb (NYSE: BMY) has suddenly become one of the most eventful big pharma names to watch as of December 1, 2025. A major lawsuit has been allowed to proceed, new cell therapy approvals are landing, hematology data at ASH 2025 is impressive, and investors are reassessing the stock’s value, dividend and medium‑term growth story. Below is a deep dive into today’s key news, current price, latest forecasts and what it all might mean for BMY stock. This article is for information only and is not investment advice. BMY Stock Snapshot on 1 December 2025 In other words: BMY is
2 December 2025
·
Newmont Stock Soars in 2025 as Gold Hits Records: Is NEM Still a Buy After UBS Lifts Target to $125?

Newmont Stock Soars in 2025 as Gold Hits Records: Is NEM Still a Buy After UBS Lifts Target to $125?

Newmont Corporation (NYSE: NEM), the world’s largest gold miner, has turned 2025 into a breakout year. As of 1 December 2025, Newmont stock trades around $91.83, up more than 100% year-to-date after a 12% surge in November alone, closely tracking gold’s march to fresh record highs. Barron’s+1 On Monday, UBS reinforced the bullish narrative, raising its price target on NEM to $125 and reiterating a Buy rating, citing strong gold fundamentals and a streamlined asset base after a wave of divestitures. GuruFocus+1 At the same time, Newmont is churning out record free cash flow, rapidly shrinking its debt load, and
2 December 2025
·
CVS Health Stock in December 2025: Price, Forecast, Dividend and Whether the Rally Still Has Room to Run

CVS Health Stock in December 2025: Price, Forecast, Dividend and Whether the Rally Still Has Room to Run

Data and news current as of December 1, 2025. This article is for informational purposes only and is not financial advice. CVS Health Stock Today: A Big 2025 Comeback, Slightly Off the Highs CVS Health Corporation (NYSE: CVS) has staged one of 2025’s quiet comeback stories. On December 1, 2025, CVS shares closed at $79.10, down about 1.6% on the day and snapping a three‑day winning streak, while the S&P 500 also slipped in a broadly weak session. The stock now sits roughly 7% below its 52‑week high of $85.15, set on October 29. MarketWatch+1 Over a longer horizon, the
2 December 2025
··
CME Group (CME) Stock: Outage Fallout, Record Volumes and 2026 Price Targets Explained

CME Group (CME) Stock: Outage Fallout, Record Volumes and 2026 Price Targets Explained

Updated December 1, 2025 CME Group Inc. (NASDAQ: CME), the world’s largest derivatives exchange operator, is ending 2025 on a complicated note. On one hand, the company is posting record volumes in key asset classes, rolling out new crypto benchmarks, launching a prediction‑markets app with FanDuel and expanding in the Middle East. On the other, a rare 10‑hour data‑center failure has put its operational resilience and competitive moat under the microscope. Here’s a deep dive into what’s moving CME Group stock today, how analysts are valuing the shares, and what to watch going into 2026. CME Group Stock Today: Price,
2 December 2025
·
Parker-Hannifin (PH) Stock Outlook December 2025: Aerospace Strength, $9.25B Filtration Deal and a Valuation Tug of War

Parker-Hannifin (PH) Stock Outlook December 2025: Aerospace Strength, $9.25B Filtration Deal and a Valuation Tug of War

As of the close on December 1, 2025, Parker‑Hannifin Corporation (NYSE: PH) is trading in the mid‑$850s per share, with a market capitalization of roughly $109 billion. MarketBeat+1 The stock has been one of the standout industrial names in 2025, powered by: At the same time, valuation is becoming a central question, with some models calling PH overvalued by ~30%, even as Wall Street’s fundamental analysts largely stay bullish. MarketBeat+3Simply Wall St+3Nasdaq+3 Below is a detailed, news‑driven look at Parker‑Hannifin stock, based on coverage and analysis published on and after December 1, 2025, plus the key corporate developments leading into
1 December 2025
KKR Stock Today (December 1, 2025): Earnings Beat, Analyst Targets and Private Credit Stress Test

KKR Stock Today (December 1, 2025): Earnings Beat, Analyst Targets and Private Credit Stress Test

As of Monday, December 1, 2025, KKR & Co. Inc. (NYSE: KKR) is trading around $122 per share, having bounced back from its autumn lows but still sitting roughly 28% below its 52‑week high of $170.40 set in late January. Yahoo Finance+2MarketWatch+2 The alternative asset manager has just delivered a strong Q3 2025 earnings beat, is facing heightened regulatory scrutiny of private credit, and still carries bullish 12‑month price targets from Wall Street. At the same time, technical and algorithmic models are more cautious in the near term, and the stock’s valuation is rich on trailing earnings. Below is a
1 December 2025
·
HCA Healthcare (HCA) Stock on December 1, 2025: Near All‑Time Highs, Upgraded Guidance and What Comes Next

HCA Healthcare (HCA) Stock on December 1, 2025: Near All‑Time Highs, Upgraded Guidance and What Comes Next

Date: December 1, 2025 – NYSE: HCA HCA Healthcare stock snapshot on December 1, 2025 HCA Healthcare, Inc. (NYSE: HCA), the largest for‑profit hospital operator in the United States, continues to trade near record territory as December begins. Barchart’s latest feature on the stock notes that HCA hit an all‑time high of $520 in the prior session and that shares have soared 71.5% year‑to‑date and 56.5% over the past 12 months, handily beating the Health Care Select Sector SPDR ETF (XLV). Barchart.com Technically, HCA has been trading above its 50‑day moving average since January and above its 200‑day moving average
1 December 2025
Honeywell (HON) Stock Today: Price, Earnings, Breakup Plan and 2026 Forecast (December 1, 2025)

Honeywell (HON) Stock Today: Price, Earnings, Breakup Plan and 2026 Forecast (December 1, 2025)

Honeywell International Inc. (NASDAQ: HON) ended Monday, December 1, 2025 at $190.22, down about 1.0% on the day and roughly 16% below its 52‑week high near $228.Danelfin AI+1 Despite a soft share price in 2025, the company just delivered a Q3 2025 earnings beat, raised its full‑year guidance, completed the Solstice Advanced Materials spin‑off, and is preparing a high‑profile breakup into separate Aerospace and Automation companies by 2026.Honeywell+2Fintool+2 At the same time, Honeywell faces growth concerns and mixed analyst sentiment: Bank of America recently double‑downgraded the stock to Underperform, while most Wall Street firms still rate HON a Buy/Moderate Buy
1 December 2025
··
MongoDB Stock Soars 15% After Q3 2026 Earnings Beat and Raised Guidance

MongoDB Stock Soars 15% After Q3 2026 Earnings Beat and Raised Guidance

NEW YORK — December 1, 2025 — MongoDB (NASDAQ: MDB) surged in extended trading on Monday after the database software company posted fiscal third‑quarter 2026 results that comfortably beat Wall Street expectations and came with a sizable guidance hike for the rest of the year. Shares jumped roughly 15% after hours to around $380, near their 52‑week high, following the report. Investors.com+1 The quarter, which ended October 31, 2025, was the first major earnings test for new CEO Chirantan “CJ” Desai, a longtime enterprise software executive who officially took the helm on November 10 after previously leading product and engineering at
1 December 2025
·
Wells Fargo (WFC) Stock on December 1, 2025: Price, Dividend, Lawsuit Settlement and 2025–2030 Forecast

Wells Fargo (WFC) Stock on December 1, 2025: Price, Dividend, Lawsuit Settlement and 2025–2030 Forecast

1. Wells Fargo stock today: price, performance and context As of the close on December 1, 2025, Wells Fargo & Company (NYSE: WFC) shares changed hands at about $85.4 per share, down just over half a percent on the day and still only a few dollars below their recent record. According to StockAnalysis data, WFC traded in a daily range of roughly $85.2–$86.5 on Monday, with volume a little over 9.2 million shares. StockAnalysis+1 Over the past year, Wells Fargo stock has enjoyed a powerful rerating. On November 12, 2025, shares hit an all‑time high of $88.54, capping a roughly
1 December 2025
·
Verizon Communications Inc. (VZ) Stock in December 2025: Earnings, 7% Dividend Yield and Frontier Deal Update

Verizon Communications Inc. (VZ) Stock in December 2025: Earnings, 7% Dividend Yield and Frontier Deal Update

Verizon stock today: price, yield and where it sits in the market As of the close on December 1, 2025, Verizon Communications Inc. (NYSE: VZ) trades around $40–41 per share, giving the company a market capitalization of roughly $173 billion.MarketBeat Key valuation metrics from recent data:MarketBeat+1 Crucially for income investors, Verizon’s quarterly dividend is $0.69 per share, or $2.76 annually following a September increase – which works out to a dividend yield of about 6.7–6.8% at today’s price.Verizon That combination – a single‑digit earnings multiple and a near‑7% yield – is exactly why Verizon continues to show up on lists
1 December 2025
···
Workday (WDAY) Stock Today: Q3 2026 Earnings, AI Strategy and Wall Street Forecasts – December 1, 2025

Workday (WDAY) Stock Today: Q3 2026 Earnings, AI Strategy and Wall Street Forecasts – December 1, 2025

Workday, Inc. (NASDAQ: WDAY) remains in the spotlight as investors digest its latest fiscal 2026 third‑quarter earnings, an aggressive push into artificial intelligence (AI), and a wave of fresh analyst forecasts published around December 1, 2025. As of the last trade on December 1, 2025, Workday shares change hands at about $213.35, down roughly 1% on the day. The stock now sits around 4% above its 52‑week low near $205 and more than 25% below its 52‑week high around $294, leaving it in a post‑earnings “reset” zone rather than at euphoric highs.WallStreetZen Below is a comprehensive look at Workday’s stock
1 December 2025
···
Union Pacific (UNP) Stock on December 1, 2025: Merger Risks, Dividend Strength and Wall Street’s 2026 Price Targets

Union Pacific (UNP) Stock on December 1, 2025: Merger Risks, Dividend Strength and Wall Street’s 2026 Price Targets

Union Pacific Corporation (NYSE: UNP) heads into December 2025 trading in the middle of its 52‑week range, with investors trying to balance a powerful earnings and efficiency story against unusually high regulatory and merger risk. At the close on December 1, 2025, Union Pacific stock changed hands at $231.36, giving the railroad giant a market value of about $137 billion. The shares sit between a 52‑week low of $204.66 and a high of $256.84, trade on roughly 19.6x trailing earnings and carry a 2.4% dividend yield based on an annualized payout of $5.52 per share.StockAnalysis Year‑to‑date, UNP has delivered a
1 December 2025
··
Amgen Stock (AMGN) Today: Q3 2025 Earnings Beat, MariTide Obesity Drug Outlook and 2030 Price Forecast

Amgen Stock (AMGN) Today: Q3 2025 Earnings Beat, MariTide Obesity Drug Outlook and 2030 Price Forecast

Updated December 1, 2025 Amgen stock at a glance on December 1, 2025 Amgen Inc. (NASDAQ: AMGN) closed today at $337.49, down about 2.3% on the session, according to real‑time quote data. StockAnalysis Despite today’s pullback, the stock has had a powerful run: Zacks notes that Amgen shares are up almost 16% over the past month, significantly outpacing the broader healthcare sector. TradingView Benzinga pegs Amgen’s 2025 year‑to‑date return at roughly 31% and 1‑year return at about 20%, with a market cap around $184–186 billion. Benzinga+2Ticker Nerd+2 Intraday, Amgen was one of the main drags on the Dow: MarketWatch highlighted
1 December 2025
·
Texas Instruments (TXN) Stock on December 1, 2025: Earnings Hangover, $60 Billion Fab Bet and What Wall Street Expects Next

Texas Instruments (TXN) Stock on December 1, 2025: Earnings Hangover, $60 Billion Fab Bet and What Wall Street Expects Next

Texas Instruments Incorporated (NASDAQ: TXN) heads into December 2025 as a classic “quality but controversial” semiconductor name: the business is strong, the dividend is rich, but investors are still digesting heavy spending and a weaker‑than‑hoped earnings outlook. As of the latest trade on December 1, 2025, TXN is around $168 per share (about $168.16), giving the company a market capitalization near $152–153 billion. The stock sits well below its 52‑week high above $220 but comfortably above its low near $140. Google+1 Below is a detailed look at the latest news, forecasts and analysis around Texas Instruments stock as of December
1 December 2025
··
Royal Bank of Canada (RY) Stock Near Record Highs Ahead of Q4 2025 Earnings: Buy, Hold or Take Profits?

Royal Bank of Canada (RY) Stock Near Record Highs Ahead of Q4 2025 Earnings: Buy, Hold or Take Profits?

Royal Bank of Canada (TSX: RY, NYSE: RY) heads into its fourth‑quarter 2025 earnings week trading close to all‑time highs and sitting at the centre of a big debate: has the post‑HSBC‑deal, AI‑powered rally gone too far, or is there more room for this Canadian banking giant to run? On the New York Stock Exchange, RY closed on December 1, 2025 at about US$152.89, with an after‑hours quote around US$154.29 — just shy of its 52‑week high of US$154.64. That gives the bank a market cap near US$217 billion, a trailing P/E of about 16.0 and a forward P/E around 14.3, according to StockAnalysis.StockAnalysis On the Toronto Stock Exchange,
1 December 2025
Chevron (CVX) Stock Today: HSBC Upgrade, CPC Drone Attack Fallout and 2030 Cash‑Flow Roadmap

Chevron (CVX) Stock Today: HSBC Upgrade, CPC Drone Attack Fallout and 2030 Cash‑Flow Roadmap

Date: December 1, 2025 Chevron Corporation (NYSE: CVX) is back in the spotlight to start December, as a fresh analyst upgrade, a high‑profile drone attack on a key export terminal and the company’s ambitious 2030 free‑cash‑flow plan all hit the tape at once. As of the latest trading on Monday, Chevron stock is changing hands around $152–153 per share, giving the U.S. supermajor a market capitalization of roughly $300 billion.MarketBeat+1 Year to date, CVX has delivered a total return of about 10.6%, while offering an annualized dividend of $6.84 per share, a forward yield of roughly 4.5%—above its five‑year average
1 December 2025
··
Suncor Energy (SU) Stock Outlook for December 2025: Dividend Hike, Q3 Earnings Beat and Rising Analyst Targets

Suncor Energy (SU) Stock Outlook for December 2025: Dividend Hike, Q3 Earnings Beat and Rising Analyst Targets

On 1 December 2025, Suncor Energy Inc. (TSX: SU, NYSE: SU) is back in the spotlight for global energy investors. The Canadian integrated oil sands producer is trading close to its 52‑week highs after a strong run through 2025, powered by record production, an earnings beat, a dividend increase and a wave of analyst upgrades. By late trading on 1 December, Suncor’s New York–listed shares change hands around US$44.80, just shy of their 12‑month peak near US$45.60 and well above the low around US$30.79.Finviz On the Toronto Stock Exchange, the stock sits near C$62–63, with MarketBeat quoting C$62.75 at the latest close.MarketBeat Below
1 December 2025
··
AbbVie (ABBV) Stock in December 2025: Atogepant Breakthrough, Q3 Beat and 2026 Outlook After Medicare Price Cuts

AbbVie (ABBV) Stock in December 2025: Atogepant Breakthrough, Q3 Beat and 2026 Outlook After Medicare Price Cuts

AbbVie Inc. (NYSE: ABBV) heads into December 2025 as one of the world’s largest healthcare companies, with new migraine data, fresh oncology approvals, a raised 2025 profit forecast and looming U.S. drug‑pricing reforms all shaping sentiment around the stock.The Motley Fool+1 Below is a detailed look at where AbbVie’s stock stands today, what has changed since late November, and how Wall Street now frames the 2026 outlook. AbbVie stock today: price, performance and valuation As of the December 1, 2025 close, AbbVie shares trade at around $225 per share, giving the company a market capitalization near $400 billion.StockAnalysis+1 Key snapshot
1 December 2025
····
Canadian Natural Resources (CNQ) Stock in 2025: Record Output, Bigger Dividends and a 2026 Growth Plan

Canadian Natural Resources (CNQ) Stock in 2025: Record Output, Bigger Dividends and a 2026 Growth Plan

As of December 1, 2025, Canadian Natural Resources Limited (TSX: CNQ, NYSE: CNQ) is trading near the upper end of its 52‑week range after posting record production, raising its 2025 guidance, announcing a 25th consecutive annual dividend increase, and outlining a plan for higher volumes with lower capital spending in 2026.Newsfile+2Reuters+2 Below is a deep dive into the latest news, numbers, analyst forecasts and key risks around CNQ stock, written for readers following energy names on Google News and Google Discover. CNQ Stock Today: Price, Valuation and Performance Snapshot On a trailing basis, recent estimates put Canadian Natural’s P/E ratio around 12–15x, depending on whether Canadian or U.S. GAAP figures and currencies are
1 December 2025
···
1 … 1,160 1,161 1,162 1,163 1,164 … 1,636

Stock Market Today

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
Go toTop